RT Book, Section
A1 Holm, Tammy M.
A1 Parangi, Sareh
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145757572
T1 Hürthle Cell Carcinoma
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK accesssurgery.mhmedical.com/content.aspx?aid=1145757572
RD 2024/04/24
AB Hürthle  cell  carcinoma  is  a  rare  subtype  of  well-differentiated  thyroid  cancer  representing  3%  to  4%  of  all  thyroid  malignancies.1  First  described  by  Max  Askanazy  in  1898  and  then  erroneously  attributed  to  Karl  Hürthle  30  years  later,  Hürthle  cell  carcinoma  continues  to  perplex  even  experienced  endocrine  surgeons  and  surgical  oncologists  due  to  the  rarity  of  disease  as  well  as  the  somewhat  variable  natural  history.